Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
32.80
-1.45 (-4.23%)
At close: Apr 23, 2026, 4:00 PM EDT
33.00
+0.20 (0.61%)
Pre-market: Apr 24, 2026, 7:28 AM EDT
Viking Therapeutics Employees
Viking Therapeutics had 53 employees as of December 31, 2025. The number of employees increased by 17 or 47.22% compared to the previous year.
Employees
53
Change
17
Growth
47.22%
Revenue / Employee
n/a
Profits / Employee
-$6,785,642
Market Cap
3.80B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| ACADIA Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Crinetics Pharmaceuticals | 594 |
| Amicus Therapeutics | 511 |
| Travere Therapeutics | 497 |
| Edgewise Therapeutics | 146 |
| Tango Therapeutics | 137 |
VKTX News
- 1 day ago - Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026 - PRNewsWire
- 14 days ago - Viking Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 4 weeks ago - Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735 - PRNewsWire
- 2 months ago - Viking Therapeutics Stock Gains Amid Obesity Drug Buzz - Benzinga
- 2 months ago - Viking Therapeutics plans to advance oral obesity drug to late-stage trial - Reuters
- 2 months ago - Viking Therapeutics Stock Climbs After Q4 Report: Details - Benzinga
- 2 months ago - Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026 - PRNewsWire